Simultaneous estimation of serum and cerebrospinal fluid adenosine deaminase level to differentiate tuberculous and non-tuberculous meningitis
Abstract
Introduction: Studies have shown the role of cerebrospinal fluid (CSF) adenosine deaminase (ADA) level but simultaneously estimation of serum and CSF-ADA to diagnose tuberculous meningitis (TBM) has been assessed rarely. Therefore, we conducted this study to assess the usefulness of serum and CSF-ADA in diagnosing TBM and to differentiate it with non-tuberculous meningitis in children.
Material & Methods: A prospective, case-control study was conducted in tertiary care institution of central India over one year. Children hospitalised with suspected meningitis were recruited and serum and CSF-ADA levels were estimated after dividing them into TBM and non-tuberculous meningitis.
Results: Out of 78 recruited cases, 36 had TBM while 42 had non-tuberculous etiology. 32 of 36 TBM cases had CSF-ADA above cut-off value (10U/L) while only 3 out of 42 controls had levels above this. Serum ADA above cut-off (60U/L) was seen in 13 TBM and 2 non-TBM cases. Mean CSF-ADA in cases (18.68±6.21 U/L) was significantly higher than in controls (5.98±2.75 U/L) (p<0.0001); however, serum ADA did not differ significantly between two groups (p=0.0631). CSF-ADA >10U/L showed 92.86% sensitivity and 88.89% specificity (area under ROC curve - 0.9742) in differentiating tuberculous from non-tuberculous meningitis; it also has 91.43% positive predictive value and 90.70% negative predictive value. Serum ADA >60IU/L has shown sensitivity of 95.24% with poor specificity of 33.33%.
Conclusion: CSF-ADA estimation is of considerable value to diagnose TBM and to differentiate it from non-tuberculous meningitis but simultaneous estimation of CSF and serum ADA has no additional benefit.
Downloads
References
2. Tuon FF, Higashino HR, Lopes I, Litvoc MN, Atomiya AN, Antonangelo L, et al. Adenosine Deaminase and Tuberculous Meningitis – A Systematic Review with Meta-Analysis. Scand J Infect Dis. 2010 Mar;42(3):198–207. [PubMed]
3. Molavi A, LeFrock JL. Tuberculous meningitis. Med Clin North Am. 1985 Mar;69(2):315-31. [PubMed]
4. Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J: Tuberculous meningitis. J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):289-99. [PubMed]
5. Moghtaderi A, Niazi A, Alavi-Naini R, Yaghoobi S, Narouie B. Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis. Clin Neurol Neurosurg. 2010 Jul;112(6):459–62. [PubMed]
6. Choi SH, Kim YS, Bae IG, Chung JW, Lee MS, Kang JM, et al. The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults. Clin Neurol Neuros. 2002 Jan;104(1):10–5. [PubMed]
7. Donald PR, Malan C, vander Walt A, Schoeman JF. The simultaneous determination of cerebrospinal fluid and plasma adenosine deaminase activity as a diagnostic aid in tuberculous meningitis. S Afr Med J. 1986 Apr 12;69(8):505-7.
8. Chaturvedi P, Vaidya J, Harinath BC, Pramanick B. Adenosine deaminase levels in cerebrospinal fluid and serum in the diagnosis of tubercular meningitis. J Trop Pediatr. 2000 Dec;46(6):378-9. [PubMed]
9. Watt G, Zaraspe G, Bautista S, Laughlin LW: Rapid diagnosis of tuberculous meningitis by using an enzyme linked immunosorbent assay to detect mycobacterial antigen and antibody in cerebrospinal fluid. J Infect Dis. 1988 Oct;158(4):681-6.
10. Katti MK: Assessment of antibody responses to antigens of Mycobacterium tuberculosis and Cysticercus cellulosae in cerebrospinal fluid of chronic meningitis patients for definitive diagnosis as TBM/NCC by passive hemagglutination and immunoblot assays. FEMS Immunol Med Microbiol. 2002 Mar 25;33(1):57-61.
11. Mathai A, Radhakrishnan VV, Sarada C, George SM: Detection of heat stable mycobacterial antigen in cerebrospinal fluid by Dot-Immunobinding assay. Neurol India. 2003 Mar;51(1):52-4. [PubMed]
12. Krambovitis E, McIllmurray MB, Lock PE, Hendrickse W, Holzel H: Rapid diagnosis of tuberculous meningitis by latex particle agglutination. Lancet. 1984 Dec 1;2(8414):1229-31. [PubMed]
13. Kashyap RS, Dobos KM, Belisle JT, Purohit HJ, Chandak NH, Taori GM, Daginawala HF: Demonstration of components of antigen 85 complex in CSF of Tuberculous meningitis patients. Clin Diagn Lab Immunol. 2005 Jun;12(6):752-8. [PubMed]
14. Rana SV, Chacko F, Lal V, Arora SK, Parbhakar S, Sharma SK, Singh K. To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis. Clin Neurol Neurosurg. 2010 Jun;112(5):424–30. [PubMed]
15. Baro M, Acevedo L, Lagos ME: Usefulness of adenosine deaminase determination in cerebrospinal fluid for the diagnosis of meningeal tuberculosis; 4 years experience at a public hospital. Rev Med Chill. 1996 Mar;124(3):319-26.
16. Pettersson T, Klockars M, Weber TH: Diagnostic value of cerebrospinal fluid adenosine deaminase determination. Scand J Infect Dis. 1991 Jan;23(1):97-100. [PubMed]
17. Blake J, Berman P: The use of adenosine deaminase assays in the diagnosis of tuberculosis. S Afr Med J. 1982 Jul 3;62(1):19-21. [PubMed]
18. Mishra OP, Loiwal V, Ali Z, Nath G, Chandra L, Das BK. Cerebrospinal fluid adenosine deaminase activity and C-reactive protein in tuberculous and partially treated bacterial meningitis. Indian Pediatr. 1995 Aug;32(8):886-9.
19. Rana SV, Singhal RK, Singh K, Kumar L. Adenosine Deaminase levels in Cerebrospinal fluid as a diagnostic test for Tuberculous Meningitis in children. Indian J Clin Biochem. 2004 Jul;19(2):5-9. [PubMed]
20. Baheti R, Laddha P, Gehlot RS. CSF-Adenosine Deaminase (ADA) Activity in Various Types of Meningitis. J Ind Acad Clin Med. 2001 Dec;2(4):285-7.
21. Cho BH, Kim BC, Yoon GJ, Choi SM, Chang J, Lee SH, et al. Adenosine deaminase activity in cerebrospinal fluid and serum for the diagnosis of tuberculous meningitis. Clin Neurol Neurosurg. 2013 Sep;115(9):1831-6.
OAI - Open Archives Initiative
